-
Views
-
Cite
Cite
Howard S. Jaffe, Ronald B. Herberman, Rationale for Recombinant Human Interferon-Gamma Adjuvant Immunotherapy for Cancer, JNCI: Journal of the National Cancer Institute, Volume 80, Issue 9, 6 July 1988, Pages 616–619, https://doi.org/10.1093/jnci/80.9.616
- Share Icon Share
This content is only available as a PDF.
© Oxford University Press
Issue Section:
Editorial
You do not currently have access to this article.